Wedbush Securities Inc. Invests $221,000 in Iqvia Holdings Inc (IQV) Stock

Wedbush Securities Inc. acquired a new position in Iqvia Holdings Inc (NYSE:IQV) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 2,256 shares of the medical research company’s stock, valued at approximately $221,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in IQV. Exxonmobil Investment Management Inc. TX bought a new position in Iqvia in the 4th quarter worth approximately $2,266,000. DnB Asset Management AS bought a new position in Iqvia in the 4th quarter worth approximately $8,813,000. First Citizens Bank & Trust Co. bought a new position in Iqvia in the 4th quarter worth approximately $1,067,000. Franklin Street Advisors Inc. NC bought a new position in Iqvia in the 4th quarter worth approximately $7,446,000. Finally, Nisa Investment Advisors LLC bought a new position in Iqvia in the 4th quarter worth approximately $920,000. 96.09% of the stock is owned by institutional investors.

In other news, Director John Connaughton sold 1,163,191 shares of Iqvia stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $102.00, for a total transaction of $118,645,482.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of Iqvia stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $102.00, for a total transaction of $764,776,314.00. The disclosure for this sale can be found here. Insiders have sold a total of 8,727,078 shares of company stock valued at $890,124,079 over the last ninety days. 6.40% of the stock is currently owned by insiders.

Iqvia Holdings Inc (NYSE:IQV) opened at $99.78 on Friday. The company has a quick ratio of 1.22, a current ratio of 1.19 and a debt-to-equity ratio of 1.21. Iqvia Holdings Inc has a fifty-two week low of $76.51 and a fifty-two week high of $110.67. The company has a market cap of $20,779.38, a price-to-earnings ratio of 16.49, a price-to-earnings-growth ratio of 1.82 and a beta of 0.61.

Iqvia (NYSE:IQV) last announced its quarterly earnings results on Wednesday, February 14th. The medical research company reported $1.32 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.34 by ($0.02). Iqvia had a net margin of 13.44% and a return on equity of 13.03%. The firm had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.14 billion. During the same period in the previous year, the business earned $1.09 earnings per share. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. equities research analysts anticipate that Iqvia Holdings Inc will post 3.97 earnings per share for the current year.

Several research analysts recently commented on IQV shares. Evercore ISI started coverage on shares of Iqvia in a report on Thursday, January 18th. They issued an “outperform” rating and a $112.00 price objective for the company. Jefferies Group raised their price objective on shares of Iqvia from $107.00 to $110.00 and gave the stock a “hold” rating in a report on Monday, October 30th. Mitsubishi UFJ Financial Group started coverage on shares of Iqvia in a report on Friday, December 15th. They issued a “neutral” rating and a $112.00 price objective for the company. SunTrust Banks reaffirmed a “hold” rating and issued a $110.00 price objective on shares of Iqvia in a report on Monday, January 22nd. Finally, Zacks Investment Research downgraded shares of Iqvia from a “hold” rating to a “sell” rating in a report on Tuesday, February 20th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Iqvia currently has an average rating of “Buy” and an average target price of $110.02.

TRADEMARK VIOLATION NOTICE: “Wedbush Securities Inc. Invests $221,000 in Iqvia Holdings Inc (IQV) Stock” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/25/wedbush-securities-inc-invests-221000-in-iqvia-holdings-inc-iqv-stock.html.

About Iqvia

IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).

Institutional Ownership by Quarter for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply